DrugPatentWatch Database Preview
Prinston Inc Company Profile
What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?
PRINSTON INC has fifty-six approved drugs.
There is one tentative approval on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 48 |
| Ingredients: | 48 |
| NDAs: | 56 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 091497-001 | Jun 6, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Prinston Inc | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 204901-002 | Nov 6, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Prinston Inc | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 206376-001 | May 7, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Prinston Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202533-002 | Jul 20, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Prinston Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208880-001 | Sep 10, 2018 | AB1 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
